United States · Seed startup

Who invested in AccurKardia

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $2.5MDec 2025
Investors
3
See who backed them

The rounds

  1. Dec 2025

Founders and team

From AccurKardia's own website and the SEC filings it signed: 3 founders, 2 on the team.

Juan C. JimenezCo-Founder & CEONamed on its 2023 Form D
Mohamed Sadeq AliCo-Founder & COONamed on its 2023 Form D
Tony M KuttiachenCo-Founder & GM Cardiac Monitoring
  • Dr. Naveed RazviChief Medical Officer
  • Moin HussainiChief Product Officer

On the board, as filediJohn Sadeq FoxNaveen Sadeq Srinivas

AdvisersDr. Andrew PedtkeKen NelsonSanjiv Arora

Everyone who backed them

Y CombinatorAccelerator1round
MedTech InnovatorAccelerator1round
Mayo ClinicInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about AccurKardia

Who invested in AccurKardia?

AccurKardia's investors include Y Combinator, MedTech Innovator and Mayo Clinic.

How much has AccurKardia raised?

AccurKardia has raised $2.5M across 1 round since 2025.

When did AccurKardia last raise?

AccurKardia's most recent round was a Seed of $2.5M in Dec 2025.

What was AccurKardia's biggest round?

Its most recent round, $2.5M in Dec 2025, is also its largest on record.

Who backed AccurKardia first?

AccurKardia's first round on record, in Dec 2025, was backed by Y Combinator, MedTech Innovator and Mayo Clinic.

What stage is AccurKardia at?

AccurKardia's latest named round is a Seed, in Dec 2025.

Where is AccurKardia based?

AccurKardia is based in the United States.

Companies like AccurKardia

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.